← back to search

Teresita L. Arenzana

Biogen (United States) · US
Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses, and Immune Cell Function and Interaction.
h-index
13
citations
1,028
works
36
NIH funding
primary concept
email

Recent publications

Pseudokinase STK40 limits T cell exhaustion through COP1-dependent degradation of AP1-family transcription factors
Nature Immunology 2025cited by 0position: middledoi
Preclinical and translational pharmacology of afucosylated anti‐CCR8 antibody for depletion of tumour‐infiltrating regulatory T cells
British Journal of Pharmacology 2024cited by 10position: middledoi
Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8
Nature Communications 2023cited by 27position: middledoi
c-Maf-dependent Treg cell control of intestinal TH17 cells and IgA establishes host–microbiota homeostasis
Nature Immunology 2019cited by 188position: middledoi
Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
Cancer Immunology Research 2019cited by 61position: middledoi
Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes
Science Immunology 2018cited by 35position: firstdoi
<i>Pten</i> Null Prostate Epithelium Promotes Localized Myeloid-Derived Suppressor Cell Expansion and Immune Suppression during Tumor Initiation and Progression
Molecular and Cellular Biology 2014cited by 136position: middledoi
Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of Ikaros
Nature Immunology 2013cited by 103position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sascha Rutz · Gilead Sciences (United States)5 papers (2018–2025)Stephen T. Smale · Howard Hughes Medical Institute2 papers (2013–2014)Zora Modrušan · Genetic Technologies (Australia)2 papers (2018–2019)James T. Koerber · Research & Diagnostic Antibodies (United States)2 papers (2023–2024) · 2 papers (2024–2025) · 2 papers (2018–2023)Seth Frietze · University of Vermont1 papers (2013–2013) · 1 papers (2019–2019)Phillip Spinosa · University of Michigan–Ann Arbor1 papers (2024–2024)Joshua D. Webster · Gene Therapy Laboratory1 papers (2018–2018)Hong Wu · Heritage Foundation1 papers (2014–2014)Tommy K. Cheung · Amgen (United States)1 papers (2018–2018)Emel Esen · Gene Therapy Laboratory1 papers (2024–2024)Jian Payandeh · Exelixis (United States)1 papers (2023–2023)Gregory Lawson · University of California, Berkeley1 papers (2013–2013)Huizhong Xiong · China Agricultural University1 papers (2019–2019)Hilde Schjerven · Oslo University Hospital1 papers (2013–2013)John Davies · University of Arizona1 papers (2024–2024)Rosa Barreira da Silva · Institut Pasteur1 papers (2025–2025)Linh M. Tran · University of Bern1 papers (2014–2014)